Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of M281 in adults with generalized myasthenia gravis com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• M281

Snippet

Sponsor: Momenta Pharmaceuticals, Inc. | Conditions: Generalized Myasthenia Gravis | Phase 2 | Status: COMPLETED | Results posted: 2021-10-27